Mustang Bio (MBIO) vs China SXT Pharmaceuticals (SXTC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Mustang Bio is the larger company by market cap ($3.2 million vs $453,907), about 7.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | MBIO | SXTC |
|---|---|---|
| Share price | $0.417 | $0.3435 |
| Market cap | $3.16M | $453.91K |
| 1-day change | -7.37% | -87.86% |
| EPS (TTM) | $-0.44 | $-730.40 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.85 | $83,760.00 |
| 52-week low | $0.4101 | $0.31 |
| Distance from 52-week high | -77.46% | -100.00% |
| Average volume | 29.24K | 3.73M |
| Shares outstanding | 6.73M | 1.32M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Mustang Bio is about 7.0 times larger than China SXT Pharmaceuticals by market value ($3.16M vs $453.91K).
MBIO vs SXTC FAQ
Which is bigger, Mustang Bio or China SXT Pharmaceuticals?
Mustang Bio (MBIO) is larger, with a market capitalization of $3.16M compared with $453.91K for China SXT Pharmaceuticals (SXTC).
Are Mustang Bio and China SXT Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.